SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-330136
Filing Date
2021-11-15
Accepted
2021-11-15 17:16:28
Documents
67
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d245471d10q.htm   iXBRL 10-Q 1355082
2 EX-31.1 d245471dex311.htm EX-31.1 6846
3 EX-31.2 d245471dex312.htm EX-31.2 7718
4 EX-32.1 d245471dex321.htm EX-32.1 6328
  Complete submission text file 0001193125-21-330136.txt   5369435

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20210930.xsd EX-101.SCH 40780
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20210930_cal.xml EX-101.CAL 35971
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20210930_def.xml EX-101.DEF 144770
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20210930_lab.xml EX-101.LAB 342890
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20210930_pre.xml EX-101.PRE 269813
10 EXTRACTED XBRL INSTANCE DOCUMENT d245471d10q_htm.xml XML 777236
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 211412456
SIC: 2834 Pharmaceutical Preparations